The Blood Group Typing Market is expected to grow at 9.8% CAGR from 2023 to 2029. It is expected to reach above USD 7.4 Billion by 2029 from USD 3 Billion in 2020.
The primary factors, advancements in new product development, and the introduction of interesting technologies all continued to have an impact on the blood group typing market.
The primary objective of the early research and development on new goods was to continue blood transfusion despite the wartime shortages. This accurate match was previously impossible based solely on antigens, however iMED demonstrated that donor blood units initially labelled as A- were another (later) AB Rhesus phenotype. Human erythrocyte electrophoresis analysis showed additional binding characteristics. Our understanding of all facets of ABO compatibility has changed as a result of this work. It ultimately resulted in the management of donor-type OPO, which was created in 1959 and became standard operating practice in 1970, by all transfusion services globally.
Blood pressure varies across individuals worldwide and is typically divided into four kinds.
The ABO Factor refers to genetic polymorphisms in the genes that encode the A or B antigens found on red blood cells. A person's blood group is determined by their underlying alleles at one of six genes, three of which have gene loci (A, B, or G), and three of which have gene loci (IA, IB, and II). ABO and Rh(D?) are the most significant blood types from a clinical perspective.
| ATTRIBUTE | DETAILS |
| Study period | 2020-2029 |
| Base year | 2021 |
| Estimated year | 2022 |
| Forecasted year | 2022-2029 |
| Historical period | 2018-2020 |
| Unit | Value (USD Billion), Volume (Thousand Units) |
| Segmentation | By Products, By Test Type, By Technique, By End User, By Region |
| By Resin Test Type
|
|
| By Test Type
|
|
| By Technique
|
|
| By End User
|
|
| By Region
|
|
ABO typing is feasible using either indirect phenotyping performed on serum antibodies or native DNA sequence as a template for PCR amplification utilizing cloned alleles as hybridization probes to produce localized DNA sequences.
One of the greatest breeds for bovine genomic diversity study is high-tritium cattle because of their high auto-segmentation reaction, which in ABO/E(P) typing indicates six genotypes. The number of people who need blood transfusions is progressively rising worldwide. Geographical location, population density, and the severity of war or medical accidents all contribute to the shortage of blood in centralized blood banks. Patients with severe inherited illnesses, such as thalassemia or sickle cell anaemia, who require ongoing transfusions throughout their lifetimes, must get transfusions from matched donors. ABO-typing is necessary to confirm that the blood groups of the donor and recipient are compatible in order to assure the success rate.
The most prevalent kind in the world is type O, and if there is a shortage, you can donate to other O's. A type AB can give to any group, but they can only receive from other types AB. Because they lack type B antigens, which indicate type A activity, type A people can only receive from other AAs and cannot donate; a person with traits for both type A1 and type A2 actions can.
Due to the COVID-19 pandemic's impact on manufacturing and supply chain concerns, decreased patient visits, and a fall in blood donations and transfusions, less of these diagnostic tools are being used. Global demand for these goods was hampered as a result. For instance, the French Blood Establishment (EFS) reports that during the height of the pandemic in September 2020, blood donations in France reached historic lows as a result of the cancellation of mobile blood collections at workplaces and universities, which were responsible for an estimated 80.0% of blood donations in France.
The pandemic in 2020 had an effect on blood group typing sales all around the world. Some well-known market participants reported a sizable reduction in annual sales income. Critical global competitors, such as Bio Rad Laboratories, Inc., for example, had a decline of 7.69% in their clinical diagnostics sectors, comprising ID-system and microplates, during FY 2020 compared to the same period in 2019. However, the business saw a 16.1% increase in sales for its clinical diagnostics division in FY 2021. However, it is projected that throughout the forecast period, the market will revert to its pre-pandemic growth levels thanks to the vigorous use of automated technology and better patient visits.
The Blood Group Typing Market size had crossed USD 3 Billion in 2020 and will observe a CAGR of more than 9.8% up to 2029.
Factors like the increasing number of road accidents, need for blood grouping to decide prenatal testing, rise in blood donations, trauma cases with a requirement for blood transfusion, and inclusion of forensic sciences would inspire better growth for the blood group typing market.
Danaher Corporation, Immucor Inc., Bio-Rad Laboratories Inc., BAG Health Care GmbH, Quotient Limited, Grifols S.A., DAY medical SA, Novacyt Group, Ortho Clinical Diagnostics Inc., Merck KGaA, Rapid Labs, CareDx Inc., AXO Science, DIAGAST and Agena Bioscience Inc. are the major blood group typing market players.
The region's largest share is in North America. Products manufactured in nations like US and Canada that perform similarly and are inexpensively accessible to the general public have led to the increasing appeal.
The Blood Group Typing Market is segmented based on Products, Test Type, Technique, End User, and Region, Global trends and forecast.
On the basis of Products, the market is segmented into Consumable, Instruments & Reagents, Services.
Consumable, Instruments and reagents & services are three product categories that can be used to segment the global market. Due to the widespread usage of these items in various processes, the Instruments and Reagents sector dominated the market. One of the main causes of segmental enlargement is the rising amount of blood donors and transfusions. During the projection period, the Services segment is expected to experience positive growth possibilities. Technology developments, strategic initiatives, and an increase in the use of sophisticated instruments for these operations are expected to boost industry growth.
On the basis of Test Type, the market is segmented into ABO Testing, Antigen Testing, Antibody Screening, Cross-Matching, HLA Testing.
Due to an increase in blood transfusions, a rise in the prevalence of chronic diseases, and prenatal testing, the antibody screening segment dominated the market. Patients who are pregnant need to undergo a number of screening procedures, such as blood group and antibody screening. Prenatal testing is becoming more common, which is accelerating the segment's growth.
In 2021, the ABO testing market category occupied the second-place spot. Segmental expansion is being boosted by the growing use of ABO blood typing to detect and match organ and tissue transplant procedures. Due to the increasing use of these tests for patients needing long-term transfusion therapy, such as those with sickle cell disease, to get phenotypically suitable units, the antigen typing category is predicted to hold the third-largest market share.
As they are used for the identification and matching of organ and tissue transplantation procedures in the region, cross-matching tests and HLA typing are also expected to expand with a sizable CAGR.
On the basis of Technique, the market is segmented into Serology Tests, Molecular Tests.
Serology testing and molecular tests are two market segments based on technology. Due to increasing efforts to encourage voluntary blood donations and new product introductions, the serology tests category held a disproportionately large percentage of the global blood group typing market. One of the more established techniques in this sector is serology testing, which can be applied in a lab setting or during a research project. Additionally, they are accessible and simple to use, which fuels the market's desire for these goods. Because molecular testing is becoming more and more popular, the market for them is expected to expand dramatically. The main driver of the segment's growth is the strong sensitivity of molecular tests to detection.
On the basis of End User, the market is segmented into Hospital Based Laboratories, Independent Laboratories & Blood Banks.
Due to an increase in independent laboratories and blood banks, notably in emerging nations, this market segment, which now holds a monopoly, is anticipated to expand. There were around 110,000 medical laboratories in India, according to a news report from the New Indian Express from March 2020. During the projection period, it is anticipated that the existence of laboratories in important countries will fuel the segment's expansion.
Hospital-based laboratories make up the second-largest market share in terms of end users. During the projection period, segmental expansion will be aided by advantageous reimbursement policies and the growing number of hospitals in developed nations. as well as independent labs & blood banks. Due to an increase in independent laboratories and blood banks, notably in emerging nations, this market segment, which now holds a monopoly, is anticipated to expand. There were around 110,000 medical laboratories in India, according to a news report from the New Indian Express from March 2020. During the projection period, it is anticipated that the existence of laboratories in important countries will fuel the segment's expansion.
[caption id="attachment_14600" align="aligncenter" width="1920"]
Danaher Corporation, Immucor Inc., Bio-Rad Laboratories Inc., BAG Health Care GmbH, Quotient Limited, Grifols S.A., DAY medical SA, Novacyt Group, Ortho Clinical Diagnostics Inc., Merck KGaA, Rapid Labs, CareDx Inc., AXO Science, DIAGAST and Agena Bioscience Inc. are the major blood group typing market players.
10 November, 2022: Danaher Corporation announced its entrance in a strategic partnership with Duke University to form its first Danaher Beacon for Gene Therapy Innovation. Danaher Beacon is a new initiative designed to access breakthrough science to create technologies and applications that will improve human health.
25 August, 2022: Bio-Rad Laboratories, Inc. introduced a range of type 1 antibodies that inhibit the binding of evolocumab to its target, human proprotein convertase subtilisin/kexin type 9, a protein that has been shown to play a key role in the regulation of cholesterol levels.
The Blood Group Typing Market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
The primary drivers of the expansion of the market under study are an increase in traffic accidents and the prevalence of chronic disorders. The United States will rank among the top countries for road traffic in July 2022, according to the Association for Safe International Road Travel, with almost 284 million vehicles on the road as of the third quarter of 2021. Additionally, it was stated that as of 2020, more than 228.7 million drivers have valid licences. The amount of traffic is one of the factors contributing to an increase in traffic accidents. Over half of the 12.15 million vehicles involved in crashes in the United States in September 2020 were passenger cars. The need for blood group typing is rising as a result of the rising number of traffic fatalities and collisions. Over the course of the forecast period, this is anticipated to increase demand for the blood group typing market.
Additionally, the need for blood transfusions is growing in the United States. According to American National Red Cross estimates, roughly 36,000 units of red blood cells are required each day, and nearly 25 million blood components are transfused in the United States annually as of October 2021. There is a great demand for blood typing in each of the aforementioned situations, and as more of these situations arise, the market will grow.
Asia-Pacific (APAC) would see the fastest market growth in the future years as a result of the rise in chronic diseases, many of which require blood type identification for efficient treatment. The market for regional blood group typing is growing quickly for several reasons, including the increasing incidence of infectious diseases and the rise in the number of trauma and accident patients who need immediate blood transfusions, for which knowing the blood type is crucial.
[caption id="attachment_14601" align="aligncenter" width="1920"]
Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.